Health & Fitness

CDC Sets Date To Talk Moderna, J&J COVID-19 Vaccine Boosters

While the CDC recently authorized booster doses of the Pfizer vaccine, Moderna and Johnson & Johnson are still waiting on the green light.

Megan VerHelst's profile picture
Megan VerHelst, Patch StaffVerified Patch Staff Badge
|
The Centers for Disease Control and Prevention has scheduled meetings in October to discuss possible authorization of booster doses of the Moderna and Johnson & Johnson COVID-19 vaccine.
The Centers for Disease Control and Prevention has scheduled meetings in October to discuss possible authorization of booster doses of the Moderna and Johnson & Johnson COVID-19 vaccine. (AP Photo/Eugene Hoshiko, File)

WASHINGTON, DC — The Centers for Disease Control and Prevention is slated to meet later this month to discuss possible authorization of booster doses of the Moderna and Johnson & Johnson COVID-19 vaccines, according to a report.

The CDC is scheduled to meet Oct. 20 and Oct. 21. The meetings will follow discussions by the U.S. Food and Drug Administration on whether to recommend green-lighting the booster shots, The Washington Post reported.

If boosters are approved, Moderna and J&J will join Pfizer, whose booster doses were granted emergency use authorization last month.

Find out what's happening in Across Americafor free with the latest updates from Patch.

Read more via The Washington Post

Get more local news delivered straight to your inbox. Sign up for free Patch newsletters and alerts.

More from Across America